Intensive cytotoxic chemotherapy.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D002455:Cell Division / Q000187:drug effects; D002822:Choriocarcinoma / Q000188:drug therapy; D006063:Chorionic Gonadotropin / Q000096:biosynthesis / Q000378:metabolism / Q000652:urine; D003609:Dactinomycin / Q000627:therapeutic use; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use; D006801:Humans; D007700:Kinetics; D002955:Leucovorin / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D051379:Mice; D008938:Mitosis / Q000187:drug effects; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology; D011247:Pregnancy; D014328:Trophoblastic Neoplasms / Q000188:drug therapy; D014747:Vinblastine / Q000627:therapeutic use
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D006063:Chorionic Gonadotropin; D005493:Folic Acid Antagonists; D003609:Dactinomycin; D014747:Vinblastine; D002955:Leucovorin; D008727:Methotrexate